R. Gimenez et J. Aguilar, EFFECTS OF CDP-CHOLINE ADMINISTRATION ON BRAIN STRIATUM PLATELET-ACTIVATING-FACTOR IN AGING RATS, European journal of pharmacology, 344(2-3), 1998, pp. 149-152
Cytidine 5'-diphosphocholine (CDP-choline) is a precursor in platelet-
activating factor (PAF) biosynthesis and it is used in the treatment o
f diseases of the central nervous system. PAF levels in the striatum o
f aged (19 months) rats were 67% lower than those found in young (2 mo
nths) animals. Chronic treatment of aged rats with CDP-choline (500 mg
/kg per day) reduced these PAF levels by more than 65% with respect to
those of untreated aged rats after 8 days of treatment. PAF subsequen
tly stabilized at these low levels as treatment continued. These resul
ts suggest that some effects of CDP-choline could be mediated by chang
es in brain PAF levels. (C) 1998 Elsevier Science B.V.